Veraxa Biotech Holding AG (VRXA) Shares Outstanding (Weighted Average) (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Shares Outstanding (Weighted Average) for 2 consecutive years, with $18.5 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 15.06% year-over-year to $18.5 million; the trailing twelve-month figure through Dec 2025 stood at $18.5 million (up 15.06% YoY), and the FY2025 full-year result was $18.5 million, up 15.06% from the prior year.
• Shares Outstanding (Weighted Average) improved to $18.5 million in Q4 2025 per VRXA's latest filing, from $16.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $18.5 million in Q4 2025 to a low of $16.0 million in Q4 2024.